CAR-T cells against CCR2b antigen expressed in B cells have potent antitumor activity against non-small cell lung cancer, with notable promise in targeting brain metastases via engineering of the CCL2/CCR2 axis [11]. The gene discussed is CCR2; the disease is non-small cell lung carcinoma.